Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Keyphrases

• Catheter-related 100%
• Renal Artery Denervation 100%
• Symplicity 100%
• Resistant Hypertension 100%
• Sham Control 65%
• Blood Pressure 30%
• Systolic Blood Pressure 30%
• Blood Pressure Control 15%
• End-stage Renal Disease 10%
• Pressure Range 10%
• Treatment Difference 10%
• All-cause Mortality 10%
• Pressure Value 10%
• Renal Artery 10%
• Embolic Event 10%
• Vascular Complications 10%
• Safety Endpoints 10%
• Hypertensive Crisis 10%
• Large Reduction 5%
• Catheter 5%
• Treatment Group 5%
• Maximum Tolerated Dose 5%
• Single Electrode 5%
• Perforation 5%
• Inclusion Criteria 5%
• Hospitalization 5%
• Non-adherence 5%
• End-organ Damage 5%
• Flex 5%
• Group Control 5%
• Rosa 5%
• Randomized Clinical Trial 5%
• Adverse Events 5%
• Antihypertensive Medication 5%
• Diuretics 5%
• Group 14 5%
• Follow-up Data 5%
• Means of Control 5%
• New Onset 5%
• Santa 5%
• Endpoint Assessment 5%
• Totality of Evidence 5%
• Adherence to Medication 5%
• Medtronic 5%
• Range Analysis 5%
• Uncontrolled Hypertension 5%
• Primary Safety 5%
• Reintervention 5%
• Medication Burden 5%
• Blood Pressure Changes 5%
• Renal Artery Stenosis 5%
• Renal Denervation 5%
• Office Blood Pressure 5%
• SD-208 5%

Medicine and Dentistry

• Denervation 100%
• Renal Artery 100%
• Resistant Hypertension 100%
• Blood Pressure 50%
• Systolic Blood Pressure 27%
• Drug Therapy 13%
• Pressure Control 13%
• End Stage Renal Disease 9%
• Diuretic Agent 4%
• Antihypertensive Agent 4%
• Group Therapy 4%
• Adverse Event 4%
• All Cause Mortality 4%
• Cause of Death 4%
• Randomized Clinical Trial 4%
• End Organ Damage 4%
• Renal Artery Stenosis 4%
• Artery Perforation 4%
• Kidney Denervation 4%
• Hypertensive Crisis 4%
• Vertebral Artery Dissection 4%

Neuroscience

• Denervation 100%
• Renal Artery 100%
• Diuretic 4%
• Stenosis 4%
• Hypertensive Emergency 4%